These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

610 related articles for article (PubMed ID: 16735149)

  • 1. Mechanisms of antimicrobial resistance in bacteria.
    Tenover FC
    Am J Med; 2006 Jun; 119(6 Suppl 1):S3-10; discussion S62-70. PubMed ID: 16735149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of antimicrobial resistance in bacteria.
    Tenover FC
    Am J Infect Control; 2006 Jun; 34(5 Suppl 1):S3-10; discussion S64-73. PubMed ID: 16813980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The role of cell wall organization and active efflux pump systems in multidrug resistance of bacteria].
    Hasdemir U
    Mikrobiyol Bul; 2007 Apr; 41(2):309-27. PubMed ID: 17682720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The clinical consequences of antimicrobial resistance.
    Rice LB
    Curr Opin Microbiol; 2009 Oct; 12(5):476-81. PubMed ID: 19716760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activity of ceftaroline (PPI-0903M, T-91825) against bacteria with defined resistance mechanisms and phenotypes.
    Mushtaq S; Warner M; Ge Y; Kaniga K; Livermore DM
    J Antimicrob Chemother; 2007 Aug; 60(2):300-11. PubMed ID: 17548456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Problems and dilemmas of antimicrobial resistance.
    Murray BE
    Pharmacotherapy; 1992; 12(6 Pt 2):86S-93S. PubMed ID: 1480504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Bacterial resistance to antibiotics].
    Moreillon P
    Schweiz Med Wochenschr; 1995 Jun; 125(23):1151-61. PubMed ID: 7597403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Recent trend and research issues related to antimicrobial-resistant bacteria].
    Yamane K; Arakawa Y
    Masui; 2010 Jan; 59(1):4-16. PubMed ID: 20077765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resistance in nonfermenting gram-negative bacteria: multidrug resistance to the maximum.
    McGowan JE
    Am J Infect Control; 2006 Jun; 34(5 Suppl 1):S29-37; discussion S64-73. PubMed ID: 16813979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of bacterial biocide and antibiotic resistance.
    Poole K
    J Appl Microbiol; 2002; 92 Suppl():55S-64S. PubMed ID: 12000613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of bacterial biocide and antibiotic resistance.
    Poole K
    Symp Ser Soc Appl Microbiol; 2002; (31):55S-64S. PubMed ID: 12481829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changing patterns of hospital infections: implications for therapy. Changing mechanisms of bacterial resistance.
    Neu HC
    Am J Med; 1984 Jul; 77(1B):11-23. PubMed ID: 6087659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associated antimicrobial resistance in Escherichia coli, Pseudomonas aeruginosa, Staphylococcus aureus, Streptococcus pneumoniae and Streptococcus pyogenes.
    Wimmerstedt A; Kahlmeter G
    Clin Microbiol Infect; 2008 Apr; 14(4):315-21. PubMed ID: 18261127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antimicrobial mechanisms of action].
    Calvo J; Martínez-Martínez L
    Enferm Infecc Microbiol Clin; 2009 Jan; 27(1):44-52. PubMed ID: 19218003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetics of antimicrobial resistance.
    Harbottle H; Thakur S; Zhao S; White DG
    Anim Biotechnol; 2006; 17(2):111-24. PubMed ID: 17127523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resistance against antimicrobial peptides is independent of Escherichia coli AcrAB, Pseudomonas aeruginosa MexAB and Staphylococcus aureus NorA efflux pumps.
    Rieg S; Huth A; Kalbacher H; Kern WV
    Int J Antimicrob Agents; 2009 Feb; 33(2):174-6. PubMed ID: 18945595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of pathogen frequency and resistance patterns among pediatric patient isolates: report from the 2004 SENTRY Antimicrobial Surveillance Program on 3 continents.
    Fedler KA; Biedenbach DJ; Jones RN
    Diagn Microbiol Infect Dis; 2006 Dec; 56(4):427-36. PubMed ID: 16938419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Determination of serum aminoglycoside and vancomycin concentrations by the microbiological method in the presence of other antimicrobials].
    Corso A; Galas MF; Rossi MA
    Rev Argent Microbiol; 1996; 28(3):123-31. PubMed ID: 9026822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Investigation of the effect of efflux pump inhibitors to MIC values of ciprofloxacin in clinical isolates of Pseudomonas aeruginosa, Escherichia coli, Acinetobacter baumannii and Staphylococcus aureus].
    Cetinkaya E; Coban AY; Durupinar B
    Mikrobiyol Bul; 2008 Oct; 42(4):553-61. PubMed ID: 19149076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimicrobial resistance and genetic characterization of fluoroquinolone resistance of Pseudomonas aeruginosa isolated from canine infections.
    Rubin J; Walker RD; Blickenstaff K; Bodeis-Jones S; Zhao S
    Vet Microbiol; 2008 Sep; 131(1-2):164-72. PubMed ID: 18395369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.